SANDUPHQ
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Sandu Pharmaceuticals Says Rakesh Parekh Resigns From Post Of CFO
Nov 22 (Reuters) - Sandu Pharmaceuticals Ltd SAPH.BO:
RAKESH PAREKH RESIGNS FROM POST OF CFO
Source text for Eikon: ID:nBSE6g789Y
Further company coverage: SAPH.BO
(([email protected];))
Nov 22 (Reuters) - Sandu Pharmaceuticals Ltd SAPH.BO:
RAKESH PAREKH RESIGNS FROM POST OF CFO
Source text for Eikon: ID:nBSE6g789Y
Further company coverage: SAPH.BO
(([email protected];))
Events:
Dividend
Dividend
Dividend
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Sandu Pharmaceutical do?
Sandu Pharmaceuticals Limited, incorporated in India in 1985, manufactures and trades Ayurvedic medicines under the brand name SANDU with a manufacturing plant in Goa.
Who are the competitors of Sandu Pharmaceutical?
Sandu Pharmaceutical major competitors are Deccan Health Care, Bacil Pharma, Roopa Industries, Shanmuga Hospital, Medicamen Organics, Walpar Nutritions, Bandaram Pharma Pack. Market Cap of Sandu Pharmaceutical is ₹51 Crs. While the median market cap of its peers are ₹50 Crs.
Is Sandu Pharmaceutical financially stable compared to its competitors?
Sandu Pharmaceutical seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Sandu Pharmaceutical pay decent dividends?
The company seems to pay a good stable dividend. Sandu Pharmaceutical latest dividend payout ratio is 52.89% and 3yr average dividend payout ratio is 47.38%
How has Sandu Pharmaceutical allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Sandu Pharmaceutical balance sheet?
Balance sheet of Sandu Pharmaceutical is strong. But short term working capital might become an issue for this company.
Is the profitablity of Sandu Pharmaceutical improving?
The profit is oscillating. The profit of Sandu Pharmaceutical is ₹1.58 Crs for TTM, ₹1.46 Crs for Mar 2024 and ₹1.52 Crs for Mar 2023.
Is the debt of Sandu Pharmaceutical increasing or decreasing?
The net debt of Sandu Pharmaceutical is decreasing. Latest net debt of Sandu Pharmaceutical is -₹2.65 Crs as of Mar-25. This is less than Mar-24 when it was -₹2.38 Crs.
Is Sandu Pharmaceutical stock expensive?
Sandu Pharmaceutical is not expensive. Latest PE of Sandu Pharmaceutical is 32.63, while 3 year average PE is 36.54. Also latest EV/EBITDA of Sandu Pharmaceutical is 17.56 while 3yr average is 18.77.
Has the share price of Sandu Pharmaceutical grown faster than its competition?
Sandu Pharmaceutical has given lower returns compared to its competitors. Sandu Pharmaceutical has grown at ~-7.9% over the last 3yrs while peers have grown at a median rate of 39.07%
Is the promoter bullish about Sandu Pharmaceutical?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Sandu Pharmaceutical is 42.9% and last quarter promoter holding is 42.9%.
Are mutual funds buying/selling Sandu Pharmaceutical?
There is Insufficient data to gauge this.